Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 7, 2019

The Functionality, Evidence and Privacy Issues around Smartphone Apps for the Top Neuropsychiatric Conditions: A Comprehensive Study (P3.9-064)

Ariana Gopal, Gabriella Sahyoun, Eric Stieglitz, John Torous, Mia Minen
First published April 16, 2019,
Ariana Gopal
1The City College of New York New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriella Sahyoun
2Barnard College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Stieglitz
3Technology Attorney New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Torous
4Harvard Medical School Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mia Minen
5NYULMC Neurology New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
The Functionality, Evidence and Privacy Issues around Smartphone Apps for the Top Neuropsychiatric Conditions: A Comprehensive Study (P3.9-064)
Ariana Gopal, Gabriella Sahyoun, Eric Stieglitz, John Torous, Mia Minen
Neurology Apr 2019, 92 (15 Supplement) P3.9-064;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: Given the volume of patients using health related smartphone applications (apps), we examined apps pertaining to the top most disabling neuropsychiatric conditions to better understand their function, privacy, and features.

Background: In 2018, ~half of 3.4 billion smartphone owners will use health-related apps. With the rapid growth of these self-management tools, great potential exists for collecting/tracking data and providing mHealth interventions, but there is little oversight into their development, data sharing, and privacy implications.

Design/Methods: Using the World Health Organization’s data of the most disabling neuropsychiatric conditions/ Disability-Adjusted-Life-Years, we generated a list of the top 5 conditions (1. Stroke, 2. Migraine, 3. Depression, 4. Alzheimer’s/Dementia, and 5. Anxiety). We systematically searched the Google Play and Apple Stores for apps for persons with those conditions. We selected the top 15 apps/store meeting pre-specified inclusion criteria: in top 50 search results, offering intervention and/or tracking capabilities, and listing the condition in the app title/description. Exclusion criteria were: $5+ to purchase, solely motor versus cognitive-based intervention, or designed for use by caregivers/healthcare providers. Content abstracted from apps and respective websites included function, behavior change rewards, and information about intervention, privacy policy, and payment.

Results: 83 apps were reviewed (Stroke n=8; Migraine n=25; Alzheimer’s/Dementia n=8; Depression n=7; Anxiety n=14; apps targeting both Depression and Anxiety n=21). 78% had a privacy policy, of which 49% were unspecific to the app. 69% of apps had an intervention component; 10 (18%) were deemed evidence-based. 70% required payment for access to all features. 19% rewarded user behavior changes.

Conclusions: There is disconnect between apps claiming to provide intervention and apps being thoroughly studied and evidence-based. Despite this, many apps requested payment to acquire full app function. Lastly, though past research suggests behavior change reward may be beneficial to app compliance, only 19% of the apps included this.

Disclosure: Dr. Gopal has nothing to disclose. Dr. Sahyoun has nothing to disclose. Dr. Stieglitz has nothing to disclose. Dr. Torous has nothing to disclose. Dr. Minen has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise